红细胞输注与不良临床结局的关联独立于心脏病史:多中心观察性InPUT研究分析
该研究基于国际ICU输血实践点患病率研究(InPUT)队列,纳入3643例重症患者,其中心脏病史(急性冠脉综合征和/或心力衰竭)者746例(20%),至少输注1单位红细胞者894例(25%)。有心脏病史与无心脏病史患者的输血率相似(25% vs 24%,p=0.51)。在输血患者中,有心脏病史者ICU期间最低血红蛋白中位数略高(7.6 g/dL vs 7.4 g/dL,p=0.007),而声明的血红蛋白输血阈值无统计学差异(8.5 g/dL vs 8.0 g/dL,p=0.11)。加权逻辑回归显示,每多输注1单位红细胞增加复合结局的比值比(OR 2.18,95%CI 1.85–2.56,p<0.0001),且与心脏病史无交互作用(p=0.44)。
要点
- 每多输注1单位红细胞,28天死亡、新发急性肾损伤或撤机失败复合结局的OR为2.18(95%CI 1.85–2.56,p<0.0001)。
- 有心脏病史与无心脏病史患者的输血率相似(25% vs 24%,p=0.51)。
- 输血患者中,有心脏病史者ICU期间最低血红蛋白中位数略高(7.6 g/dL vs 7.4 g/dL,p=0.007)。
- 声明的血红蛋白输血阈值在有心脏病史与无心脏病史患者间无统计学差异(8.5 g/dL vs 8.0 g/dL,p=0.11)。
- 红细胞输注与复合结局的关联与心脏病史无交互作用(p=0.44)。
适用人群与场景
- 重症监护病房患者,来自国际ICU输血实践点患病率研究(InPUT)队列,共3643例。
- 心脏病史定义为急性冠脉综合征和/或心力衰竭,共746例(20%)。
研究设计与关键结果
- 研究类型:多中心观察性研究(InPUT队列分析),样本量3643例。
- 有心脏病史者746/3643例(20%),至少输注1单位红细胞者894/3643例(25%)。
- 输血率:有心脏病史 vs 无心脏病史为25% vs 24%(p=0.51)。
- 输血患者中ICU期间最低血红蛋白中位数:有心脏病史7.6 g/dL vs 无心脏病史7.4 g/dL(p=0.007)。
- 声明的血红蛋白输血阈值:有心脏病史8.5 g/dL vs 无心脏病史8.0 g/dL(p=0.11)。
- 每多输注1单位红细胞与复合结局的OR为2.18(95%CI 1.85–2.56,p<0.0001)。
- 红细胞输注与心脏病史的交互作用p=0.44。
证据类型、等级与局限
- 证据类型:多中心观察性研究(InPUT队列分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Red-blood-cell (RBC) transfusion is one of the most frequent interventions in critical care patients. While patients with acute cardiac conditions are more likely to receive transfusions at higher haemoglobin thresholds than other critically ill patients, data on RBC transfusion practice for critically ill patients with pre-existing cardiac conditions are scarce. METHODS: Using the International Point-Prevalence Study of Intensive-Care Unit Transfusion Practices cohort, weighted logistic regression investigated the association between the RBC units transfused and the primary composite outcome of 28-day mortality, new-onset acute kidney injury or ventilatory weaning failure. Interactions with cardiac history (acute coronary syndrome and/or heart failure) were tested. RESULTS: Cardiac history was present in 746 of 3643 patients (20%) and 894 of 3643 (25%) received at least one RBC unit. Transfusion rates were similar in patients with and without cardiac history (25% vs. 24%; p = 0.51). Among transfused patients, median nadir haemoglobin during ICU stay was slightly higher in those with cardiac history (7.6 g/dL vs. 7.4 g/dL respectively; p = 0.007), whereas stated haemoglobin transfusion threshold did not statistically differ (8.5 g/dL vs. 8.0 g/dL; p = 0.11). Each additional RBC unit increased the odds of the composite outcome in the whole cohort (2.18, 95% CI 1.85–2.56, p < 0.0001), without interaction with cardiac history (p = 0.44). CONCLUSIONS: RBC transfusion was commonly and similarly prescribed in critically ill patients with or without cardiac history. Each additional unit was associated with a worse outcome with no evidence of differential effect due to cardiac history. TRIAL REGISTRATION: NL9049 (Dutch Trial Register), registered on 16 November 2020.
参考来源
- Kimmoun A, Girerd N, Duarte K, et al. Association between red blood cell transfusion and adverse clinical outcomes is Independent of cardiac history: a multicenter observational InPUT study analysis. Crit Care. 2025. PMID: 41413913. doi:10.1186/s13054-025-05745-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。